Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
13/02/2015 | 16:05 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
09/05/2014 | 16:07 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
05/05/2014 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
29/04/2014 | 22:59 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
29/04/2014 | 22:49 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
29/04/2014 | 22:30 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
29/04/2014 | 15:46 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
28/04/2014 | 22:22 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
28/04/2014 | 13:28 | Marketwired | Pierre Fabre Laboratories Selects QUMAS DocCompliance to Manage Quality Documents Across Entire Organization | NASDAQ:ACCL | Accelrys, Inc. (MM) |
24/04/2014 | 12:06 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
17/04/2014 | 14:00 | PR Newswire (US) | New ScienceCloud Mobile Applications by Accelrys Drive Collaborative Drug Discovery | NASDAQ:ACCL | Accelrys, Inc. (MM) |
10/04/2014 | 14:00 | PR Newswire (US) | Accelrys® Speeds Life Science Decisions with Next-Generation Insight® | NASDAQ:ACCL | Accelrys, Inc. (MM) |
09/04/2014 | 10:10 | Dow Jones News | Dassault Systemes Extends Offer for Accelrys | NASDAQ:ACCL | Accelrys, Inc. (MM) |
27/03/2014 | 22:40 | PR Newswire (US) | Dr. David B. Agus to Present Keynote Address on the End of Illness at Accelerate2014 | NASDAQ:ACCL | Accelrys, Inc. (MM) |
26/03/2014 | 08:23 | Dow Jones News | Dassault Systèmes Extends Offer for Accelrys | NASDAQ:ACCL | Accelrys, Inc. (MM) |
20/03/2014 | 13:58 | Marketwired | Biogen Idec to Present on Best Practices for Leveraging Quality and Regulatory Compliance Management Software on Apple iPads | NASDAQ:ACCL | Accelrys, Inc. (MM) |
20/03/2014 | 13:53 | Zacks | ORBCOMM (ORBC) Crumbles: Stock Falls by 6% - Tale of the Tape | NASDAQ:ACCL | Accelrys, Inc. (MM) |
20/03/2014 | 13:00 | PR Newswire (US) | Accelrys Science Council Adds Three New Fellows Supporting Scientific Research and Innovation | NASDAQ:ACCL | Accelrys, Inc. (MM) |
10/03/2014 | 11:01 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
04/03/2014 | 14:47 | Marketwired | Amneal Pharmaceuticals Implements QUMAS Compliance and Quality Management Solution | NASDAQ:ACCL | Accelrys, Inc. (MM) |
03/03/2014 | 14:00 | PR Newswire (US) | Accelrys Capture Drives Next-generation Mobility in the Laboratory | NASDAQ:ACCL | Accelrys, Inc. (MM) |
26/02/2014 | 14:00 | PR Newswire (US) | Accelrys Notebook 5.0 Sets New Standards for Moving from Paper-Based to Digital Laboratories | NASDAQ:ACCL | Accelrys, Inc. (MM) |
25/02/2014 | 22:05 | Business Wire | Accelrys Announces Fourth Quarter and Full Year 2013 Results | NASDAQ:ACCL | Accelrys, Inc. (MM) |
19/02/2014 | 18:26 | Business Wire | INVESTOR ALERT – ACCELRYS INC: The Law Offices of Vincent Wong Investigates the Sale of ACCELRYS INC. to Dassault Systemes ... | NASDAQ:ACCL | Accelrys, Inc. (MM) |
19/02/2014 | 14:00 | PR Newswire (US) | Accelrys-sponsored Presentations at SmartLab Exchange Span Research and Laboratory Informatics | NASDAQ:ACCL | Accelrys, Inc. (MM) |
19/02/2014 | 01:15 | Business Wire | ACCELRYS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Notifies Accelrys Inc. (ACCL) Investors of Claims against Company Directors ... | NASDAQ:ACCL | Accelrys, Inc. (MM) |
13/02/2014 | 23:28 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
13/02/2014 | 23:27 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:ACCL | Accelrys, Inc. (MM) |
13/02/2014 | 22:05 | PR Newswire (US) | Accelrys Introduces the Accelrys Science Council Featuring Pioneers Committed to Scientific Excellence and Awareness | NASDAQ:ACCL | Accelrys, Inc. (MM) |
12/02/2014 | 17:34 | Marketwired | INVESTOR ALERT: LEVI & KORSINSKY, LLP Notifies Investors of ACCELRYS INC. of Claims of Breaches of Fiduciary Duty Against Boa... | NASDAQ:ACCL | Accelrys, Inc. (MM) |